Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Gross Margin (2020 - 2025)

Historic Gross Margin for Volitionrx (VNRX) over the last 6 years, with Q3 2025 value amounting to 52.81%.

  • Volitionrx's Gross Margin rose 692200.0% to 52.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 183.36%, marking a year-over-year increase of 1841700.0%. This contributed to the annual value of 334.89% for FY2024, which is 4477500.0% up from last year.
  • According to the latest figures from Q3 2025, Volitionrx's Gross Margin is 52.81%, which was up 692200.0% from 156.59% recorded in Q2 2025.
  • Over the past 5 years, Volitionrx's Gross Margin peaked at 52.81% during Q3 2025, and registered a low of 12661.52% during Q4 2021.
  • For the 5-year period, Volitionrx's Gross Margin averaged around 1928.07%, with its median value being 875.18% (2024).
  • Data for Volitionrx's Gross Margin shows a peak YoY increase of 486850800bps (in 2021) and a maximum YoY decrease of -80001000bps (in 2021) over the last 5 years.
  • Volitionrx's Gross Margin (Quarter) stood at 12661.52% in 2021, then surged by 90bps to 1301.87% in 2022, then soared by 48bps to 678.32% in 2023, then rose by 18bps to 553.09% in 2024, then soared by 90bps to 52.81% in 2025.
  • Its last three reported values are 52.81% in Q3 2025, 156.59% for Q2 2025, and 272.3% during Q1 2025.